Login
← Go Back
Windlas Biotech
WINDLAS · Pharma > Pharmaceuticals & Drugs · Chairman: Vivek Dhariwal · MD: Hitesh Windlass · Listing date: Aug. 17, 2021 · Employees: 1028 · Gurugram · http://windlasbiotech.com
Stock Price vs Company Growth
1d
0.5%
1w
1.0%
1m
7.7%
3m
16.7%
6m
45.1%
1y
144.4%
all
33.2%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 1,032 0.5%
822
1,197
Company Overview
Sales
696 Cr
Growth: 19.2%
Profit after Tax
61.2 Cr
Growth: 2.7%
Small Cap
2,156 Cr
P/E: 35.2x
Industry P/E: 37.3x
Fundamentals
Sales (Cr) ₹ 696
Growth 19.2%
EBITDA 12.4%
P/S 3.1x
Dividend 1.0%
P/E 35.2x
Book Value ₹ 229
PEG Ratio 1.8x
ROE 13.3%
P/B 4.5x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The company provides pharmaceutical development services, large-scale manufacturing services and authentic yet affordable products to its customers and consumers around the world. Awards, accreditations and recognitions2018: The company was awarded the TV100 Industrial Excellence Award in the field of medicine.
Belongs to (4 Indices)
Investors (1)
jainam.b...